AssetMark Inc
CRMD icon

AssetMark Inc’s CorMedix CRMD Stock Holding History

AssetMark Inc’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$169 Buy
+22
New +$176 ﹤0.01% 3636

Other funds holding CRMD

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Wingate Wealth Advisors
Wingate Wealth Advisors Lexington, Massachusetts $241M AUM 12.37% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
PIP
Palisades Investment Partners Santa Monica, California $344M AUM 44.86% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

AssetMark Inc's CRMD Position: Q3 2026 in Review

AssetMark Inc opened a new position in CorMedix (CRMD) in Q3 2026: 22 shares worth $169. The stake represents ﹤0.01% of the portfolio and ranks #3636 among its holdings.

50 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • AssetMark Inc held 22 shares of CorMedix worth $169 as of Q3 2026.
  • CorMedix was a new AssetMark Inc position in Q3 2026.
  • CorMedix made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3636 holding.
  • 50 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.